[go: up one dir, main page]

ZA962242B - Storage-stable drug forms. - Google Patents

Storage-stable drug forms.

Info

Publication number
ZA962242B
ZA962242B ZA9602242A ZA962242A ZA962242B ZA 962242 B ZA962242 B ZA 962242B ZA 9602242 A ZA9602242 A ZA 9602242A ZA 962242 A ZA962242 A ZA 962242A ZA 962242 B ZA962242 B ZA 962242B
Authority
ZA
South Africa
Prior art keywords
pct
drug forms
storage
stable drug
date sep
Prior art date
Application number
ZA9602242A
Other languages
English (en)
Inventor
Joerg Breitenbach
Jens Rieger
Joerg Rosenberg
Axel Sanner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA962242B publication Critical patent/ZA962242B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
ZA9602242A 1995-03-21 1996-03-20 Storage-stable drug forms. ZA962242B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19509806A DE19509806A1 (de) 1995-03-21 1995-03-21 Lagerstabile Arzneiformen

Publications (1)

Publication Number Publication Date
ZA962242B true ZA962242B (en) 1997-09-22

Family

ID=7757017

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9602242A ZA962242B (en) 1995-03-21 1996-03-20 Storage-stable drug forms.

Country Status (16)

Country Link
US (1) US5945127A (xx)
EP (1) EP0814781B1 (xx)
JP (1) JPH11502208A (xx)
AT (1) ATE213153T1 (xx)
AU (1) AU5105196A (xx)
BR (1) BR9607796A (xx)
CA (1) CA2213720A1 (xx)
DE (2) DE19509806A1 (xx)
DK (1) DK0814781T3 (xx)
ES (1) ES2172655T3 (xx)
HU (1) HUP9801151A3 (xx)
IL (1) IL117530A (xx)
NO (1) NO974337L (xx)
PT (1) PT814781E (xx)
WO (1) WO1996029060A1 (xx)
ZA (1) ZA962242B (xx)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602206A1 (de) * 1996-01-23 1997-07-24 Basf Ag Zubereitungen nichtsteroidaler Analgetika
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
ES2307482T3 (es) 1999-02-10 2008-12-01 Pfizer Products Inc. Dispersiones farmaceuticas solidas.
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
CA2359945C (en) * 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US7067148B2 (en) * 2001-02-15 2006-06-27 King Pharmaceutical Research & Development, Inc. Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
US20030224047A1 (en) * 2001-02-15 2003-12-04 Franz G. Andrew Levothyroxine compositions and methods
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US20030032675A1 (en) * 2001-02-15 2003-02-13 Franz G. Andrew Manufacture of thyroid hormone tablets having consistent active moiety amounts
US20030180353A1 (en) * 2001-08-10 2003-09-25 Franz G. Andrew Stabilized pharmaceutical compositions
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030190349A1 (en) * 2001-08-10 2003-10-09 Franz G. Andrew Methods of stabilizing pharmaceutical compositions
US20030198667A1 (en) * 2001-08-10 2003-10-23 Franz Andrew G. Methods of producing dispersible pharmaceutical compositions
US20030199586A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Unique levothyroxine aqueous materials
US20030195253A1 (en) * 2001-08-14 2003-10-16 Franz G. Andrew Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration
US7101569B2 (en) 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20030198672A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique triidothyronine plasma AUC properties
US20030199587A1 (en) * 2001-08-14 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique Cmax properties
US20030203967A1 (en) * 2001-08-14 2003-10-30 Franz G. Andrew Levothyroxine compositions having unique Tmax properties
US20040015519A1 (en) * 2001-10-15 2004-01-22 Yukitoshi Maeda Content delivery server and content delivery system having the same
US20030190350A1 (en) * 2001-10-29 2003-10-09 Franz G. Andrew Levothyroxine compositions having unique triiodothyronine Tmax properties
CN1681479A (zh) 2002-08-12 2005-10-12 辉瑞产品公司 半有序药物和聚合物的药物组合物
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8476233B2 (en) * 2003-08-29 2013-07-02 Therapeutic Research, Llc Methods for treatment for ulcerative colitis in mammals
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
GB0403098D0 (en) * 2004-02-12 2004-03-17 Euro Celtique Sa Extrusion
BRPI0609910A2 (pt) * 2005-05-10 2010-05-11 Novartis Ag composições farmacêuticas de famciclovir de liberação modificada
AU2006244213B2 (en) * 2005-05-10 2010-05-13 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds
AU2011224098B2 (en) * 2005-05-10 2013-10-31 Novartis Ag Extrusion process for making compositions with poorly compressible therapeutic compounds
US9109068B2 (en) 2005-07-21 2015-08-18 Akzo Nobel N.V. Hybrid copolymer compositions
US7666963B2 (en) * 2005-07-21 2010-02-23 Akzo Nobel N.V. Hybrid copolymers
US8674021B2 (en) 2006-07-21 2014-03-18 Akzo Nobel N.V. Sulfonated graft copolymers
US20080020961A1 (en) * 2006-07-21 2008-01-24 Rodrigues Klin A Low Molecular Weight Graft Copolymers
EP2112925A4 (en) * 2006-11-15 2013-01-09 Abbott Lab SOLID PHARMACEUTICAL DOSAGE FORMULATIONS
US8613834B2 (en) 2008-04-03 2013-12-24 Basf Se Paper coating or binding formulations and methods of making and using same
US8853144B2 (en) 2011-08-05 2014-10-07 Ecolab Usa Inc. Cleaning composition containing a polysaccharide graft polymer composition and methods of improving drainage
US8679366B2 (en) 2011-08-05 2014-03-25 Ecolab Usa Inc. Cleaning composition containing a polysaccharide graft polymer composition and methods of controlling hard water scale
US8636918B2 (en) 2011-08-05 2014-01-28 Ecolab Usa Inc. Cleaning composition containing a polysaccharide hybrid polymer composition and methods of controlling hard water scale
US8841246B2 (en) 2011-08-05 2014-09-23 Ecolab Usa Inc. Cleaning composition containing a polysaccharide hybrid polymer composition and methods of improving drainage
MX2014005094A (es) 2011-11-04 2014-08-08 Akzo Nobel Chemicals Int Bv Copolimeros de dendrita hibridos, composiciones de los mismos y metodos para producirlos.
EP2773321B1 (en) 2011-11-04 2015-09-09 Akzo Nobel Chemicals International B.V. Graft dendrite copolymers, and methods for producing the same
US9687010B2 (en) * 2012-03-14 2017-06-27 Mccormick & Company, Incorporated Extrusion encapsulation of actives at an increased load, using surface active plant extracts
US8945314B2 (en) 2012-07-30 2015-02-03 Ecolab Usa Inc. Biodegradable stability binding agent for a solid detergent
EP3181120A1 (en) 2012-11-09 2017-06-21 Scidose LLC Enema composition for treatment of ulcerative colitis having long term stability
US9365805B2 (en) 2014-05-15 2016-06-14 Ecolab Usa Inc. Bio-based pot and pan pre-soak

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520180A (en) * 1982-09-20 1985-05-28 Gaf Corporation Polymerization of vinylpyrrolidone to various molecular weights using a single initiator system consisting essentially of t-Butylperoxypivalate
US4712460A (en) * 1985-11-18 1987-12-15 Biotrack, Inc. Integrated drug dosage form and metering system
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen

Also Published As

Publication number Publication date
EP0814781B1 (de) 2002-02-13
DK0814781T3 (da) 2002-03-18
IL117530A0 (en) 1996-07-23
NO974337D0 (no) 1997-09-19
DE59608732D1 (de) 2002-03-21
ES2172655T3 (es) 2002-10-01
EP0814781A1 (de) 1998-01-07
US5945127A (en) 1999-08-31
ATE213153T1 (de) 2002-02-15
JPH11502208A (ja) 1999-02-23
DE19509806A1 (de) 1996-09-26
CA2213720A1 (en) 1996-09-26
IL117530A (en) 1999-12-31
HUP9801151A2 (hu) 1998-08-28
PT814781E (pt) 2002-07-31
WO1996029060A1 (de) 1996-09-26
BR9607796A (pt) 1998-07-07
NO974337L (no) 1997-09-19
AU5105196A (en) 1996-10-08
HUP9801151A3 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
IL117530A (en) Storage-stable drug forms
AU4786096A (en) Solid active agent preparations
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
AU5106996A (en) Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby
ATE293458T1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
DE69727922D1 (de) Schnell zerfallende orale dosierungsform
FI95768B (fi) Emättimensisäinen antosysteemi
AU1099288A (en) Drug delivery system and method of making the same
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
PL324690A1 (en) Improved therapeutic agents
FR2735132B1 (fr) Medicament polypeptidique modifie, composition et dispositif d'administration par electrotransport le contenant
GEP20063719B (en) Prevention of Migraine Recurrence
ATE173399T1 (de) Retardtablette mit einem gehalt an diclofenac-na
ATE206911T1 (de) Feste arzneimittelform mit polymerem material verteiltem wirkstoff
GR3026551T3 (en) Composition of polymers for medical applications.
AU5690496A (en) Polyketone polymer composition
AU5696194A (en) Methylbutoxy-propionitriles and their use as perfumes
FR2696066B1 (fr) Procédé pour transmettre des messages, et unité fonctionnelle et installation s'y rapportant.
UA23119A (uk) Психотропhий засіб
MX9606041A (es) Forma de dosificacion de rapida disolucion.